Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

The comparative efficacy of intramuscular antipsychotics for the management of acute agitation.

Bosanac P, Hollander Y, Castle D.

Australas Psychiatry. 2013 Dec;21(6):554-62. doi: 10.1177/1039856213499620. Epub 2013 Aug 31. Review.

PMID:
23996795
2.

Management of agitation in the acute psychotic patient--efficacy without excessive sedation.

Cañas F.

Eur Neuropsychopharmacol. 2007 Mar;17 Suppl 2:S108-14. Review.

PMID:
17336765
3.

The utility of intramuscular ziprasidone in the management of acute psychotic agitation.

Mendelowitz AJ.

Ann Clin Psychiatry. 2004 Jul-Sep;16(3):145-54.

PMID:
15517847
4.

A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.

MacDonald K, Wilson M, Minassian A, Vilke GM, Becker O, Tallian K, Cobb P, Perez R, Galangue B, Feifel D.

J Clin Psychopharmacol. 2012 Jun;32(3):317-22. doi: 10.1097/JCP.0b013e318253a2fe.

PMID:
22544013
5.

Best clinical practice with ziprasidone IM: update after 2 years of experience.

Zimbroff DL, Allen MH, Battaglia J, Citrome L, Fishkind A, Francis A, Herr DL, Hughes D, Martel M, Preval H, Ross R.

CNS Spectr. 2005 Sep;10(9):1-15. Review.

PMID:
16247923
6.

Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.

Castle DJ, Udristoiu T, Kim CY, Sarosi A, Pidrman V, Omar AN, Rosales JI, Melamed Y, Isik T, Karagianis J, Treuer T.

World J Biol Psychiatry. 2009;10(1):43-53. doi: 10.1080/15622970802688051.

PMID:
19137460
7.
8.

Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial.

Tran-Johnson TK, Sack DA, Marcus RN, Auby P, McQuade RD, Oren DA.

J Clin Psychiatry. 2007 Jan;68(1):111-9.

PMID:
17284138
9.

Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia.

Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, Deng H, Li K, Gao C, Wang X, Vanderburg D, Pan S, Tang H, Shu L, Karayal ON.

J Clin Psychopharmacol. 2013 Apr;33(2):178-85. doi: 10.1097/JCP.0b013e3182839612.

PMID:
23422376
10.

Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.

Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD.

Curr Med Res Opin. 2006 Nov;22(11):2209-19.

PMID:
17076982
11.

Pharmacological management of acute agitation.

Battaglia J.

Drugs. 2005;65(9):1207-22. Review.

PMID:
15916448
12.

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.

Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP.

Psychopharmacology (Berl). 2001 May;155(2):128-34.

PMID:
11401000
13.
14.

A prospective, observational study of the safety and effectiveness of intramuscular psychotropic treatment in acutely agitated patients with schizophrenia and bipolar mania.

Perrin E, Anand E, Dyachkova Y, Wagner T, Frediani S, Ballerini A; OBS-IM investigators group.

Eur Psychiatry. 2012 May;27(4):234-9. doi: 10.1016/j.eurpsy.2010.04.005. Epub 2010 Jul 9.

PMID:
20620029
15.

Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.

Daniel DG, Currier GW, Zimbroff DL, Allen MH, Oren D, Manos G, McQuade R, Pikalov AA 3rd, Crandall DT.

J Psychiatr Pract. 2007 May;13(3):170-7.

PMID:
17522560
17.

Intramuscular aripiprazole in the acute management of psychomotor agitation.

De Filippis S, Cuomo I, Lionetto L, Janiri D, Simmaco M, Caloro M, De Persis S, Piazzi G, Simonetti A, Telesforo CL, Sciarretta A, Caccia F, Gentile G, Kotzalidis GD, Girardi P.

Pharmacotherapy. 2013 Jun;33(6):603-14. doi: 10.1002/phar.1260. Epub 2013 Mar 15.

PMID:
23505124
18.

[New formulations of olanzapine in the treatment of acute agitation].

Bartkó G.

Neuropsychopharmacol Hung. 2006 Dec;8(4):171-8. Review. Hungarian.

PMID:
17211052
19.

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP.

J Clin Psychiatry. 2001 Jan;62(1):12-8. Erratum in: J Clin Psychiatry 2001 Mar;62(3):209.

PMID:
11235922

Supplemental Content

Support Center